COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy*†-Reference-Cited by-同舟云学术

COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy*†

Published:2010-09-06 Issue:2 Volume:9 Page:141-148
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:

Author:

Belshaw Z.,Constantio-Casas F.,Brearley M. J.,Dunning M. D.,Holmes M. A.,Dobson J. M.

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5829.2010.00243.x/fullpdf

Reference33 articles.

1. Neoplasms of the nasal passages and paranasal sinuses in domesticated animals as reported by 13 veterinary colleges.;Madewell;American Journal of Veterinary Research,1976

2. Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors.;Lana;Veterinary Radiology and Ultrasound,2004

3. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003).;Rassnick;Journal of the American Veterinary Medical Association,2006

4. Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors.;Adams;Veterinary Radiology and Ultrasound,2009

5. Outcome of accelerated radiotherapy alone or accelerated radiotherapy followed by surgical exenteration of the nasal cavity in dogs with intranasal neoplasia: 53 cases;Adams;Journal of the American Veterinary Medical Association,2005

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of vascular endothelial growth factor receptor-2, epidermal growth factor receptor, cyclooxygenase-2, survivin, E-cadherin and Ki-67 in canine nasal carcinomas and sarcomas – a pilot study;Frontiers in Veterinary Science;2024-08-29

2. Pan-tumour analysis of COX-2 expression in dogs;The Veterinary Journal;2024-04

3. Olfactory neuroblastoma in a domestic cat and review of the literature;Veterinary Clinical Pathology;2023-07-19

4. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma;Journal of Veterinary Diagnostic Investigation;2023-01-17

5. Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma;Journal of Veterinary Medical Science;2023